MELVILLE, N.Y. –
December 14, 2020– Comtech Telecommunications Corp. (NASDAQ: CMTL) announced today, that during its second quarter of fiscal 2021, its New York-based subsidiary, Comtech PST Corp., which is part of Comtech’s Government Solutions segment, received a follow-on contract award for $3.5 million for solid-state, high-power RF amplifiers from a major domestic medical instrumentation provider.
These amplifiers are used by one of the world’s largest supplier of image-guided radiotherapy (“IGRT”) and image-guided intensity modulated radiation therapy (“IMRT”) medical equipment, providing state-of-the-art solutions for the treatment of cancer. These advanced forms of treatment deliver versatile complex doses of radiation at greater speed and accuracy, thereby minimizing damage to surrounding healthy tissue.
In commenting on this contract award, Fred Kornberg, Chairman of the Board and Chief Executive Officer of Comtech Telecommunications Corp. said, “This significant award demonstrates Comtech’s strength in delivering solid-state, high-power RF amplifiers for medical systems and we look forward to continuing to address this important market.”
Comtech PST Corp. (www.comtechpst.com) is a leading independent supplier of broadband, high-power, high performance RF microwave amplifiers and control components for use in a broad spectrum of applications including defense, medical, satellite communications systems and instrumentation.
Comtech Telecommunications Corp. progetta, sviluppa, produce e commercializza prodotti, sistemi e servizi innovativi per soluzioni di comunicazione avanzate. L'azienda vende prodotti a una base di clienti diversificata nei mercati globali delle comunicazioni commerciali e governative.
Alcune informazioni contenute nel presente comunicato stampa contengono dichiarazioni di natura previsionale che comportano rischi e incertezze significativi. I risultati effettivi potrebbero differire materialmente da tali informazioni previsionali. I documenti della Commissione per i Titoli e gli Scambi della Società identificano molti di questi rischi e incertezze. Tutte le informazioni previsionali contenute nel presente comunicato stampa sono qualificate nella loro interezza dai rischi e dalle incertezze descritte in tali documenti della Commissione per i Titoli e gli Scambi.
PCMTL
View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005212/en/
Contatto con i media:
Michael D. Porcellana, Presidente e Direttore operativo
631-962-7000
[email protected]
